• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

MELANOMA

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

TP53 CTLA4 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE PSEUDOMONAS AERUGINOSA STREPTOCOCCUS PNEUMONIAE INSULIN FOXP3 IL17A IFNG HELICOBACTER PYLORI IMMUNE RESPONSE CASP3 DIABETES MELLITUS ANGIOGENESIS PARKINSON DISEASE ALZHEIMER'S DISEASE CELL DIFFERENTIATION AUTOPHAGY ERBB-2 TNF NEURODEGENERATIVE DISORDERS CANCER APOPTOTIC PROCESS BREAST CANCER DOXORUBICIN CANDIDA ALBICANS IL6 RHEUMATOID ARTHRITIS TH17 CELLS INFLAMMATION SOD1 PORPHYROMONAS GINGIVALIS CELL PROLIFERATION ESCHERICHIA COLI LISTERIA MONOCYTOGENES STAPHYLOCOCCUS AUREUS AGING METFORMIN IL23A CELL DEATH CELL DIVISION CLOSTRIDIUM DIFFICILE REMICADE RECEPTOR CD4

© 2019 Biovista Vizit All Rights Reserved.